Hook & thesis
NMI Holdings is a private mortgage guaranty insurer that looks attractively priced right now. The shares trade near $37.76 with a market cap of roughly $2.87 billion, a P/E around 7.4 and a P/B near 1.11. Those multiples understate how capital-light the business can be and how robust recent profitability has been: reported EPS of $5.12 and return on equity near 15% suggest core economics that justify a higher multiple even if growth smooths from recent highs.
In short: earnings may have peaked, but the combination of strong book-value expansion, meaningful free cash flow generation and relatively low leverage creates a favorable risk/reward. This is an upgrade to a long trade with explicit entry, stop and target on a multi-month horizon.
What the company does and why the market should care
NMI provides private mortgage guaranty insurance, backing loans made to borrowers who put down less than 20%. The business is sensitive to mortgage origination volumes, credit performance and the pricing of mortgage insurance, but generates outsized returns when underwriting discipline, favorable credit trends and steady premium growth align.
Why investors should care now: NMI is delivering profitable underwriting and robust capital metrics at a cyclically attractive valuation. Recent disclosures point to strong book value growth and notable quarterly profitability, while balance-sheet ratios show a conservative financial posture that reduces tail-risk for equity holders.
Facts and numbers that matter
| Metric | Value |
|---|---|
| Current price | $37.76 |
| Market cap | $2.87B |
| EPS (trailing) | $5.12 |
| P/E | ~7.4x |
| P/B | ~1.11x |
| ROE | ~15% |
| Free cash flow | $412.5M |
| Debt / Equity | ~0.16 |
Concrete signals of recent performance: management commentary and filings indicate book value grew by about 15% year-over-year, and Q1 net income was reported near $99.3 million. Those items show the company has been able to grow book value while generating strong underwriting returns. Enterprise-value multiples are also conservative: EV/EBITDA around 6.0 and EV/Sales roughly 4.59, which in an insurance context signals a valuation that’s more consistent with a mid-cycle earnings profile than a peak-cycle premium.
Valuation framing
The simplest way to look at valuation here is peer-agnostic: at $37.76 the stock is trading at ~7.4x trailing earnings and just above book. For a business with a 15% ROE and meaningful free cash flow, those multiples imply either an expectation of declining returns or elevated near-term losses. Neither looks locked in: capital adequacy is healthy (low leverage and explicit PMIER compliance guidance), and free cash flow of roughly $412.5 million provides flexibility for capital allocation or buybacks that would support a higher share price.
Put differently, a re-rating to even mid-teens P/E would produce material upside without relying on a return to the peak growth of prior quarters. If earnings stabilize or decline modestly from recent peaks but book value keeps compounding, equity holders still benefit through multiple expansion or eventual capital return.
Catalysts (what could drive the trade)
- Quarterly results showing continued book-value growth and a return to disciplined loss ratios, which would validate the underwriting thesis and support multiple expansion.
- Regulatory clarity and continued compliance with revised PMI eligibility requirements - confirmation reduces regulatory risk and can unlock investor confidence.
- Evidence of capital deployment (share buybacks or opportunistic reinsurance moves) funded by the ~$412M free cash flow run-rate or retained earnings.
- Housing-market steadiness or improving credit performance that lowers expected loss rates and supports margin recovery.
Trade plan (actionable)
Thesis: Buy NMIH as a long trade to capture valuation re-rating and book-value compounding, while accepting that earnings may modestly decelerate from recent highs.
Entry: $37.76
Stop loss: $34.00
Target: $46.00
Horizon: long term (180 trading days). I expect this trade to play out over multiple quarters because the best re-rating catalysts are incremental: quarterly book-value disclosures, regulatory confirmations, and capital deployment decisions. Short-term noise around mortgage origination cycles or headline macro data could cause volatility; give the thesis time to develop over roughly six months.
Rationale for levels: the stop sits below the recent 52-week low area and gives room for normal volatility while protecting capital if credit trends or regulatory outcomes deteriorate. The target assumes a modest re-rating to the low double-digit P/E and continued book-value gains; it also leaves upside if the company announces capital returns or materially improves loss ratios.
Position sizing and risk management
This is a medium-risk trade: the company has conservative leverage and strong cash generation, but the mortgage-insurance business is cyclical and sensitive to credit losses. Limit allocation to a size appropriate for your portfolio risk tolerance (we recommend no more than 2-4% of total portfolio capital for a single-name trade at this stop distance) and be prepared to trim into strength or add only on material, validated deterioration in price with improved fundamentals.
Technical and market structure notes
Technicals are neutral to slightly bearish in the near term - 10/20/50-day averages cluster in the upper $37–$38 range and RSI sits in the mid 40s. Short interest translates to a days-to-cover metric around 3-5 days historically, so the stock can move quickly on headline news but is not an extreme short-squeeze candidate. Use position sizing and the stop above to respect this volatility profile.
Risks and counterarguments
- Peaking or declining earnings: If mortgage volumes and premium growth fall materially and underwriting deteriorates, EPS could decline. That would pressure P/E multiples and the share price. Counterargument: even with earnings normalizing, strong book-value growth and free cash flow offer valuation support and a buffer for equity holders.
- Credit-cycle deterioration: A worsening housing or borrower-credit environment would raise loss ratios and could deplete capital. This is the principal business risk for mortgage insurers and would justify a lower valuation.
- Regulatory changes: Stricter capital requirements or changes to PMIERs could force additional capital or alter permissible business lines. While NMI has guided compliance, new regime interpretations could still be disruptive.
- Interest-rate driven origination slump: Prolonged lower mortgage origination volumes compress new premium flows. Even if in-force book profits persist, slower new business could limit growth and investor enthusiasm.
- Market multiple compression: Even without company-specific issues, a broader risk-off move in financials or insurance stocks could compress multiples and offset fundamental resilience.
What would change my mind
I would downgrade this trade if: (a) management signals a material decline in capital adequacy or the company fails to demonstrate compliance with PMIERs; (b) quarterly loss ratios materially and persistently deteriorate beyond current guidance; or (c) free cash flow collapses and there is no credible plan for capital allocation or shareholder-friendly actions. Conversely, a demonstration of sustained book-value compounding above the recent 15% pace or explicit capital-return programs would make me more aggressive on size and shorten the time horizon.
Conclusion
NMIH is an actionable long with a clear, risk-limited trade plan. At roughly $37.76 the valuation is conservative relative to the company’s return profile and cash-generation capacity. While earnings may have peaked and the business remains cyclical, strong capital metrics and continued book-value growth provide a margin of safety. Enter at $37.76 with a stop at $34.00 and a target of $46.00 over the next 180 trading days, and manage exposure to reflect the cyclical risk that defines mortgage insurance.
Trade entry: $37.76 | Stop: $34.00 | Target: $46.00 | Horizon: long term (180 trading days)